Ms. WANG Honglan
(HKPFS Awardee)
PhD Student (2022- 2025)
Education Background:
- Bachelor of Pharmaceutics, China Pharmaceutical University, P.R. China
- MS in Pharmaceutics, China Pharmaceutical University, P.R. China
Research Topics:
- Formulation science
My Aspiration:
- “I aspire to discover synergistic drug combinations and novel drug co-delivery systems for the treatment of lung infection.”
Publication:
- Wang H, Zeng P, Zhang P, Zuo Z, Liu Y, Xia J, Lam JKW, Chan HK, Leung SSY. Phage-derived polysaccharide depolymerase potentiates ceftazidime efficacy against Acinetobacter baumannii pneumonia via low-serum-dependent mechanisms. Int J Biol Macromol. 2024 Dec;282(Pt 6):137486.
doi: 10.1016/j.ijbiomac.2024.137486. Epub 2024 Nov 9. PMID: 39528188. - Wang H, Liu Y, Bai C, Leung SSY. Translating Bacteriophage-Derived Depolymerases into Antibacterial Therapeutics: Challenges and Prospects. Acta Pharm Sin B. 2024 Jan;14(1):155-169.
doi: 10.1016/j.apsb.2023.08.017.
Award/ Scholarship:
- Hong Kong PhD Fellowship
- CUHK Vice-Chancellor HKPFS Scholarship
- Second-Prize Poster Award (2024), awarded by Alliance Phage of China (APC) at The 7th Frontier Forum on Superbug Infection and Bacteriophage Control in Aug 2024 at Shanghai, China